H.C. Wainwright Reiterates Buy Rating on NRx Pharmaceuticals, Inc. (NRXP)

April 27, 2026 6:49 AM

H.C. Wainwright analyst Vernon Bernardino reiterated a Buy rating and $45.00 price target on NRx Pharmaceuticals, Inc. (NASDAQ: NRXP).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found